Adam Koppel resigned from the board of PTC Therapeutics Inc.
His decision was based on the need to focus on his principal work activities and not due to any disagreement with the company.
PTC Therapeutics director resigns
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective
PTC Therapeutics director resigns
- Author Mirza Salam Ahmed
- Theme Healthcare & Pharmaceuticals
- Author
- Mirza Salam Ahmed
- Theme
- Healthcare & Pharmaceuticals